Dr. Paul David Rosenblit, MD
- Medicare services, 2024
- 855
- Medicare patients, 2024
- 433
- Part D claims, 2024
- 13,684
- Publications
- 34
- Clinical trials
- 4
- Practice address
- 18821 Delaware St, Huntington Beach, CA 92648-1926
- Practice phone
- Call (714) 375-5572
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Diabetes/Lipid Management & Research Center
Physician office · Huntington Beach, California
Find Dr. Rosenblit's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Paul David Rosenblit is an endocrinologist in Huntington Beach, California
Dr. Rosenblit practices at Diabetes/Lipid Management & Research Center in Huntington Beach, California.
Dr. Rosenblit's NPI, 1699862102, was assigned on October 6, 2006. Dr. Rosenblit graduated from Universidad Autonoma de Ciudad Juarez in 1981. Dr. Rosenblit holds California license A39224.
- NPI
- 1699862102NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0648442798
- NPI enumeration date
- October 6, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (714) 375-5572
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 71
- Medical school graduation
- 1981
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Paul David Rosenblit practices at Diabetes/Lipid Management & Research Center in Huntington Beach, California
Dr. Rosenblit's primary practice is Diabetes/Lipid Management & Research Center, at 18821 Delaware St, Huntington Beach, CA 92648-1926. The practice phone is (714) 375-5572.
- Diabetes/Lipid Management & Research Center18821 Delaware St, Huntington Beach, CA 92648-1926Phone(714) 375-5572
Source: Dmand AI Affiliation Data
Dr. Paul David Rosenblit is affiliated with 5 sites of care and 1 medical group
Dr. Rosenblit's primary practice is Diabetes/Lipid Management & Research Center in Huntington Beach, California. Dr. Rosenblit is also affiliated with UCI Health - Orange. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Rosenblit to 3 more hospitals, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Paul David Rosenblit's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosenblit practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Diabetes/Lipid Management & Research Center | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Paul David Rosenblit is one of 1,062 endocrinologists in California
Endocrinology, diabetes and metabolism is Dr. Rosenblit's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Rosenblit is board certified in clinical lipidology by the American Board of Clinical Lipidology. Dr. Rosenblit is licensed in California.
Specialties and state licenses
- Endocrinology, diabetes and metabolism, CaliforniaPrimary
Clinical focus
Dmand AI lists acute mini-stroke (TIA), bronchitis, chronic anemia, chronic diabetes, chronic hypertension, coronary artery disease, diabetic emergency and enlarged prostate among the conditions Dr. Rosenblit treats.
Endocrinologists near Dr. Rosenblit
Counts of endocrinologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Paul David Rosenblit billed Medicare for 855 services in 2024
CMS data shows 855 Medicare services from Dr. Rosenblit across 5 procedure codes in 2024, for 433 Medicare patients. Medicare paid $95,352 for them.
Dr. Rosenblit's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 9612024: 85511%
Where Dr. Rosenblit's Medicare services took place, 2024
- In an office84198%
- In a facility142%
Dr. Rosenblit compared with the California median for endocrinologists, 2024
- Dr. Rosenblit
- California median
- Medicare services
- 855vs 67527% above
- Medicare patients
- 433vs 24080% above
- Part D claims
- 13,000vs 1,10411.8 times
Medians across 994 endocrinologists in California with Dmand AI profiles that report each measure.
Dr. Rosenblit's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Rosenblit?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Rosenblit and other endocrinologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Paul David Rosenblit treated 433 Medicare patients in 2024, average age 76
CMS counts 433 Medicare patients who saw Dr. Rosenblit in 2024. The largest group is 65 to 74, with 171 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Rosenblit's median patient age at 69, with 57% women.
Dr. Rosenblit's Medicare patients by age, 2024
Dr. Rosenblit's Medicare patients by sex, 2024
- Women22853%
- Men20547%
Chronic conditions among Dr. Rosenblit's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Diabetes67%
- Arthritis48%
- Chronic kidney disease45%
- Ischemic heart disease36%
- Osteoporosis28%
- Mood disorders19%
Share of Medicare patients with each condition. A patient can have several.
Dr. Rosenblit's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women57%
- Men41%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Paul David Rosenblit wrote 13,684 Medicare Part D claims in 2024
In 2024, Dr. Rosenblit wrote 13,684 Medicare Part D claims for 938 patients. 70% of them were for generic drugs. CMS names the drug for 13,000 of them, across 99 drugs with 11 or more claims each, at $4,361,324 in total drug cost. In 2023, CMS named 12,918 claims across 108 drugs.
Dr. Rosenblit's Part D claims by kind of drug, 2024
- Generic9,542 claims70%
- Brand-name3,928 claims29%
- Other214 claims2%
Dr. Rosenblit's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Rosenblit's Part D claims, 2024
- Antibiotics0%16 of 13,684 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 12,9182024: 13,0001%
Drugs named by CMS: 99 in 2024, 108 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Paul David Rosenblit scored 86 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Rosenblit for performance year 2024, reported individually. Dr. Rosenblit accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Rosenblit's MIPS scores, performance year 2024
- 86of 100Final score
- 100of 100Quality
- 40of 100Improvement Activities
- 44of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Paul David Rosenblit has 34 publications on record
Dmand AI links 34 papers to Dr. Rosenblit, published from 2013 to 2019. 2017 was the busiest year, with 6. The most frequent topics are Algorithms, Diabetes Mellitus, Type 2 and Cardiovascular Diseases. Dr. Rosenblit has published most often in Endocr Pract. Dr. Rosenblit's most frequent co-authors are Yehuda Handelsman, MD, Paul Stephen Jellinger, MD and Irl B. Hirsch.
Dr. Rosenblit's papers by year, 2013 to 2019
Topics Dr. Rosenblit writes about most
- Algorithms
- Diabetes Mellitus, Type 2
- Cardiovascular Diseases
- Consensus
- Endocrinologists
- Hypoglycemic Agents
- Blood Glucose
- Diabetes Mellitus
Dr. Rosenblit's most frequent co-authors
- Yehuda Handelsman, MD20 shared papers
- Paul Stephen Jellinger, MD19 shared papers
- Irl B. Hirsch15 shared papers
Recent publications by Dr. Rosenblit
Expert Rev Cardiovasc Ther
See who Dr. Rosenblit researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Rosenblit works with, so you can find a warm path to the right endocrinologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Paul David Rosenblit has worked on 4 clinical trials
Dmand AI links Dr. Rosenblit to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Diabetes Mellitus, Type 2, Diabetes Mellitus and Hyperalgesia. Open Payments lists research payments to Dr. Rosenblit that name 2 trials.
Conditions in Dr. Rosenblit's trials
- Diabetes Mellitus, Type 2
- Diabetes Mellitus
- Hyperalgesia
- Myocardial Infarction
- Infarction
Investigators on the most trials with Dr. Rosenblit
- Ahmed A. Arif, MD2 shared trials
- Fahed Georgeos Bitar, MD2 shared trials
- Michael Edward Dever, MD2 shared trials
Recent clinical trials with Dr. Rosenblit
Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD (opens in a new tab)
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Paul David Rosenblit received $301,514 in industry payments from 2016 to 2025
CMS Open Payments shows 1,420 general payments to Dr. Rosenblit from 64 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Merck Sharp & Dohme Corporation paid the most, $64,471. It also lists 196 research payments totaling $41,005 from 2016 to 2022, naming 2 clinical trials.
General payments to Dr. Rosenblit by program year, 2016 to 2025
General payments to Dr. Rosenblit by kind, 2016 to 2025
- Speaker and faculty fees$165,03055%
- Consulting fees$63,13521%
- Food and beverage$39,33713%
- Travel and lodging$33,57811%
- Other$4350%
Companies that paid Dr. Rosenblit the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Paul David Rosenblit has 3 awards and honors on record
Dmand AI lists 3 awards for Dr. Rosenblit, most recently Fellow (FNLA) in 2009. Dr. Rosenblit serves on 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015 and AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2035.
Awards and honors for Dr. Rosenblit
- 2009
- Fellow (FNLA)
- Undated
- AACE Fellow
- Checkbook Top Doc
Source: Dmand AI Professional Profile Data
Dr. Paul David Rosenblit graduated from Universidad Autonoma de Ciudad Juarez
Dr. Rosenblit graduated from Universidad Autonoma de Ciudad Juarez in 1981. Dr. Rosenblit is a member of AACE, ADA, American Society of Preventive Cardiology, CMA, ENDO and NLA.
- Medical school
- Board certified in clinical lipidology
- Board certified in endocrinology, diabetes and metabolism
- Board certified in internal medicine
Source: Dmand AI Professional Profile Data
Dr. Paul David Rosenblit accepts plans from 8 insurance carriers
Dr. Rosenblit is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.
- Aetna
- Blue Cross Blue Shield of Michigan
- Elevance
- Humana
- Blue Cross Blue Shield of Massachusetts
- HCSC
- Regence Health Plans
- CMS Medicare
Plan types Dr. Rosenblit accepts, by number of carriers
- Medicare8
- PPO7
- HMO4
- EPO2
- POS2
Source: Dmand AI Insurance Network Data
Sources for Dr. Paul David Rosenblit's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Paul David Rosenblit
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Paul David Rosenblit's NPI number?
Dr. Paul David Rosenblit's NPI number is 1699862102. It was assigned on October 6, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Paul David Rosenblit?
Dr. Paul David Rosenblit is an endocrinologist in Huntington Beach, California. The primary specialty in the NPI Registry is Endocrinology, Diabetes & Metabolism Physician (taxonomy code 207RE0101X).
Where does Dr. Paul David Rosenblit practice?
Dr. Rosenblit practices at 18821 Delaware St, Huntington Beach, CA 92648-1926. Dr. Rosenblit's primary practice is Diabetes/Lipid Management & Research Center in Huntington Beach, California. Dmand AI also links Dr. Rosenblit to 3 hospitals.
What is Dr. Paul David Rosenblit's office phone number?
The practice phone on file for Dr. Rosenblit is (714) 375-5572.
What is Dr. Paul David Rosenblit's medical license number?
Dr. Rosenblit holds California license A39224.
Which hospitals is Dr. Paul David Rosenblit affiliated with?
Dr. Rosenblit is affiliated with UCI Health - Orange. Dmand AI links Dr. Rosenblit to 3 more hospitals.
What medical group is Dr. Paul David Rosenblit part of?
Dr. Rosenblit is linked to UCI Health Physicians.
Does Dr. Paul David Rosenblit accept Medicare?
Yes. CMS data shows Dr. Rosenblit billed Medicare for 855 services in 2024, and Dr. Rosenblit accepts Medicare assignment.
What is Dr. Paul David Rosenblit's MIPS score?
Dr. Rosenblit's MIPS final score for performance year 2024 is 86 out of 100, reported individually.
How many Medicare patients does Dr. Paul David Rosenblit see?
CMS counts 433 Medicare patients who saw Dr. Rosenblit in 2024, with an average age of 76.
Show 9 more questionsShow fewer questions
Is Dr. Paul David Rosenblit board certified?
Yes. Dr. Rosenblit is board certified in clinical lipidology by the American Board of Clinical Lipidology.
What services does Dr. Paul David Rosenblit bill to Medicare?
In 2024, Dr. Rosenblit's most billed Medicare services were office visit, established patient (99214), office visit, new patient (99205) and office visit, established patient (99215).
Where did Dr. Paul David Rosenblit go to medical school?
Dr. Rosenblit graduated from Universidad Autonoma de Ciudad Juarez in 1981.
What drugs does Dr. Paul David Rosenblit prescribe most?
In 2024 Medicare Part D data, Dr. Rosenblit's most prescribed drugs by claims were Ezetimibe, Pioglitazone HCl and Levothyroxine Sodium.
Has Dr. Paul David Rosenblit received payments from drug or device companies?
CMS Open Payments shows $301,514 in general payments to Dr. Rosenblit from 64 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Paul David Rosenblit been practicing?
Dr. Rosenblit graduated from medical school in 1981, 45 years ago.
Does Dr. Paul David Rosenblit do research?
Dmand AI links 34 publications to Dr. Rosenblit, published from 2013 to 2019. Dr. Rosenblit has worked on 4 clinical trials.
Who does Dr. Paul David Rosenblit publish with?
Dr. Rosenblit's most frequent co-authors are Yehuda Handelsman, MD (20 shared papers), Paul Stephen Jellinger, MD (19 shared papers) and Irl B. Hirsch (15 shared papers).
What insurance does Dr. Paul David Rosenblit accept?
Dr. Rosenblit is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.
Selling to endocrinology, diabetes and metabolism practices?
See endocrinologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card